Partial Inhibition of the Overactivated Ku80-dependent DNA Repair Pathway Rescues Neurodegeneration in -ALS/FTD
Overview
Authors
Affiliations
GGGGCC (GC) repeat expansion in is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). One class of major pathogenic molecules in -ALS/FTD is dipeptide repeat proteins such as poly(GR), whose toxicity has been well documented in cellular and animal models. However, it is not known how poly(GR) toxicity can be alleviated, especially in patient neurons. Using as a model system in an unbiased genetic screen, we identified a number of genetic modifiers of poly(GR) toxicity. Surprisingly, partial loss of function of Ku80, an essential DNA repair protein, suppressed poly(GR)-induced retinal degeneration in flies. Ku80 expression was greatly elevated in flies expressing poly(GR) and in iPSC-derived patient neurons. As a result, the levels of phosphorylated ATM and P53 as well as other downstream proapoptotic proteins such as PUMA, Bax, and cleaved caspase-3 were all significantly increased in patient neurons. The increase in the levels of Ku80 and some downstream signaling proteins was prevented by CRISPR-Cas9-mediated deletion of expanded GC repeats. More importantly, partial loss of function of Ku80 in these neurons through CRISPR/Cas9-mediated ablation or small RNAs-mediated knockdown suppressed the apoptotic pathway. Thus, partial inhibition of the overactivated Ku80-dependent DNA repair pathway is a promising therapeutic approach in ALS/FTD.
Proteins Associated with Neurodegenerative Diseases: Link to DNA Repair.
Khodyreva S, Dyrkheeva N, Lavrik O Biomedicines. 2025; 12(12.
PMID: 39767715 PMC: 11673744. DOI: 10.3390/biomedicines12122808.
repeat expansion creates the unstable folate-sensitive fragile site FRA9A.
Mirceta M, Schmidt M, Shum N, Prasolava T, Meikle B, Lanni S NAR Mol Med. 2024; 1(4):ugae019.
PMID: 39669124 PMC: 11632612. DOI: 10.1093/narmme/ugae019.
Jin S, Tian Y, Hacker J, Chen X, Bertolio M, Reynolds C Sci Adv. 2024; 10(48):eadq3350.
PMID: 39602529 PMC: 11601204. DOI: 10.1126/sciadv.adq3350.
Al-Khayri J, Ravindran M, Banadka A, Vandana C, Priya K, Nagella P Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459030 PMC: 11510162. DOI: 10.3390/ph17101391.
The exocyst subunit EXOC2 regulates the toxicity of expanded GGGGCC repeats in C9ORF72-ALS/FTD.
Halim D, Krishnan G, Hass E, Lee S, Verma M, Almeida S Cell Rep. 2024; 43(7):114375.
PMID: 38935506 PMC: 11299523. DOI: 10.1016/j.celrep.2024.114375.